CD274 and non-small cell lung carcinoma: Specifically in patients with newly diagnosed NSCLC and resected brain metastases, where biopsies of the primary tumor or extracranial metastases are not (yet) available for PD-L1 assessment, intracranial PD-L1 TPS could inform clinicians about patients who would benefit from ICI therapy.